Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

William Adrian Hall MD
Associate Professor
Department of Radiation Oncology

OFFICE ADDRESS:
Froedtert East Clinics
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone: 414-805-4477
Fax: 414-805-4369

EDUCATION:
2001 - 2005 BA, Marquette University College of Engineering, Milwaukee, WI
2005 - 2009 MD, Loyola University of Chicago, Maywood, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
2009 - 2010 Preliminary Medicine Internship, Emory University, Atlanta, GA
2010 - 2014 Residency, Radiation Oncology, Emory University, Atlanta, GA

FACULTY APPOINTMENTS:
07/2014 - 06/2015 Instructor, Radiation Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
07/2015 - 06/2018 Assistant Professor, Radiation Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
07/2018 - Present Associate Professor, Radiation Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
07/2018 - Present Secondary Faculty-Associate Professor of Surgery, Surgery, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226

HOSPITAL STAFF PRIVILEGES:
07/2014 - Present Froedtert Hospital, Milwaukee, WI
07/2014 - 07/2015 St. Catherine's Hospital, United Hospital Systems, Kenosha, WI
07/2014 - Present Froedtert West Bend Hospital, WI
07/2014 - Present Froedtert Menomonee Falls Hospital, WI
07/2014 - Present Children's Hospital of Wisconsin, Milwaukee, WI
07/2014 - Present Veteran's Administration Hospital, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Radiology (Therapeutic Radiology)
05/20/2015
05/20/2025
 
Licensure
Number Issue DateExpiration
Wisconsin
61696-20
10/31/2007
10/31/2023
 

AWARDS AND HONORS:
2004 - 2005 Marquette University, College of Engineering Deans List
2008 ASTRO Travel Grant
2011 Second Place Award, Emory Radiation Oncology Residents Research Day
2012 Radiation Therapy Oncology Group (RTOG) Resident Fellow, September
2012 First Place Award, Emory Radiation Oncology Residents Research Day
2013 Scholars in Training (SIT) Travel Grant, Radiation Research Society
2013 First Place Award, Emory Radiation Oncology Resident Research Day
2014 Best of ASTRO Abstract Recognition
2014 RSNA Resident Roentgen Resident Research Award
2016 ASCO: Methods in Clinical Cancer Research Participant; Vail CO, ASCO
2017 Dr. J Frank Wilson Award for Excellence in Resident Teaching, Medical College of Wisconsin
2018 Best of ASTRO Abstract Recognition
2019 ASTRO Best of Biology Award, ASTRO
11/18/2020 Outstanding Medical Student Teacher, Medical College of Wisconsin
09/23/2021 2021 ROI Publication Recognition , ROI
10/27/2021 2021 Outstanding Graduate Student Educator Award, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2005 - 2009 American Medical Student Association
2009 - 2014 Member in Training (American Society for Radiation Oncology)
2009 - 2014 Member in Training, Radiologic Society of North America
2014 - Present Member (American College of Radiology)
2014 - Present Member (American Society of Therapeutic Radiology and Oncology)
06/2019 - Present Society of Nuclear Medicine and Molecular Imaging (Committee Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
11/01/2020 - Present Associate Editor "Frontiers in Oncology-Cancer Imaging and Image-directed Interventions"
2021 - Present Associate Editor: Urologic Oncology: Seminars and Original Investigations
Editorial Board
06/2015 - 07/2019 Neurosurgery Journal

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
07/01/2013 - 06/30/2014 Member, ARRO Website and Social Media Subcommittee Team, ASTRO
01/01/2016 - 01/01/2019 Non-CRC Core Committee, NRG Oncology
01/01/2016 - 01/01/2019 CRC Core Committee, NRG Oncology
01/01/2016 - 01/01/2019 General GI Committee, NRG Oncology
02/14/2017 - Present Radiation Oncology Pancreatic Cancer Committee Member, ASTRO Radiation Oncology Pancreatic Cancer Guideline Task Force Member, ASTRO
07/01/2019 - 06/30/2020 Member, GI Resource Panel, ASTRO
07/01/2020 - 06/30/2021 Member, GI Resource Panel, ASTRO
2020 - Present GU Committee Lead Post-Op Prostate, NRG Oncology
2020 - Present GU Task Force, NCI
2020 - Present GI Task Force, NCI
2020 - Present Pancreatic, Small Bowel, Hepatobiliary Lead, GI ASCO Planning Committee, ASCO

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Coordination of Joint Clinical Research Activities within MR-Linac Consortium
Source:
Elekta Instruments AB
Role:
Principal Investigator
PI:
William Hall, MD
Dates:
01/01/2017 - 06/30/2022
Direct Funds:
$251,689 (Coordination of Activites within the Atlantic MR Linac Consortium )
 
Title:
NIH KL2TR001438 Development of a global metric of radiation sensitivity through the integration of imaging predictors of radiation response with genomic metrics of response
Source:
Advancing a Healthier Wisconsin Research and Education Program
Role:
CTSI Mentored Career Development Award
PI:
William Hall, MD
Dates:
02/15/2020 - 02/15/2022
Direct Funds:
$217,702 (Focus on Genomically and Radiographically Adjusted Radiation Dose)
 
Title:
Machine Learning Accelerated Online Adaptive Replanning
Source:
1R01CA247960-01 NIH/NCI
Role:
Co-Investigator
PI:
X. Allen Li, PhD
Dates:
04/01/2020 - 03/31/2025
Direct Funds:
$2,468,803 (Summary: The overall goal of this proposal is to develop and test a novel machine learning accelerated online adaptive replanning (MOLAR) solution for MRI guided radiation therapy. )
 
Title:
Prostate Cancer Radio-pathomics for Differentiating Clinically Significant Disease
Source:
1R01CA24988 NIH/NCI
Role:
Co-Investigator
PI:
Peter LaViolette
Dates:
03/01/2021 - 02/20/2026
Direct Funds:
$217,702 (Summary: In this proposal we are characterizing radiomic changes in tumor that can be seen on MRI during a treatment course with radiation therapy for prostate cancer. The goal is to understand how these changes relate to pathology and clinical outcomes. )
 
Title:
Differential immune responses to stereotactic versus conventional radiation therapy in pancreatic cancer
Source:
We Care Fund, Medical College of Wisconsin, Department of Surgery
Role:
PI
PI:
William A. Hall
Dates:
09/01/2021 - 08/31/2023
Direct Funds:
$100,000 (Examination of different immune responses to either stereotactic body radiation therapy or conventionally fractionated chemo-RT using single cell RNA seq)
 
Title:
Adaptive MR Guided Radiation Therapy For Rectal Adenocarcinoma (MR Enhance Trial)
Source:
The Bobbie Nick Voss Charitable Fund
Role:
PI
PI:
William Hall, MD
Direct Funds:
$117,000
 
Prior
Peer Review
Title:
Grant for Summer Research in Laboratory of Dr. Allen Samarel, Loyola University School of Medicine
Source:
Cardiovascular Institute
Role:
Principal Investigator
PI:
William Hall, MD
Dates:
2006
Direct Funds:
$3,500
 
Title:
Achievement Rewards for Collegiate Scientists
Source:
ARCS Foundation Chicago Research Support
Role:
Principal Investigator
PI:
William Hall, MD
Dates:
2008 - 2009
Direct Funds:
$10,000
 
Title:
The Correlation of C-Reactive Protein with Biochemical Failure and Cancer Specific Outcomes Following Radiation Therapy for Adenocarcinoma of the Prostate
Source:
American Cancer Society Grant # 14-247-29-IRG
Role:
Principal Investigator
PI:
William Hall, MD
Dates:
01/01/2015 - 12/31/2018
Direct Funds:
$50,000
 
Title:
Novel Prostate Biomarkers of Aggressive Disease
Source:
National Institutes of Health (NIH), LRP Recipient, # HWYY2136
Role:
Principal Investigator
PI:
William Hall, MD
Dates:
08/2016 - 08/2018
Direct Funds:
$70,000
 
Title:
Biomarkers, Imaging, and Quality of Life Studies: Validation of the MR-TRG Score and Central Rectal MRI Collection and Interpretation In NRG Oncology GI-002
Source:
National Cancer Institute (NCI), Biomarkers, Imaging Studies and Quality of Life Funding Program (BIQSFP)
Role:
PI (MCW sub-contract; direct funds $20,039)
PI:
Norman Wolmark, MD
Dates:
03/01/2017 - 02/28/2019
Direct Funds:
$211,481
 
Title:
“MRI in Patients with Adenocarcinoma of the Prostate for the Prediction of Radiation Therapy Response and Toxicity”
Source:
Center for Imaging Research (CIR), Daniel M. Soref Charitable Trust
Role:
Principal Investigator
PI:
William Hall, MD
Dates:
09/20/2017 - 09/20/2018
Direct Funds:
$5,000
 
Title:
Bayesian learning alogrithms for identifying and classifying heterogeneity of cell types in variety of solid tumors
Source:
NIH/NCI
Role:
Co-I
PI:
Anjishnu Banerjee
Dates:
09/01/2018 - 08/31/2020
Direct Funds:
$108,750
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Hall, WA, Introduction to Radiation Oncology, Radiation Oncology Interest Group, Emory University School of Medicine, 05/22/2011
Hall, WA, Advances in Stereotactic Body Radiosurgery, Radiation Oncology Interest Group, Emory University School of Medicine, 07/11/2012
Hall, WA, Curing Unresectable Pancreatic Adenocarcinoma: A Clinical Reality?, Radiation Oncology Grand Rounds, 01/2015
Hall, WA, Advances in Stereotactic Body Radiation Therapy for Borderline and Unresectable Adenocarcinoma of the Pancreas, HPB Lecture Series, Froedtert and the Medical College of Wisconsin, 08/06/2015
Hall, WA, Stereotactic Radiation, Medical Staff Education Program, St. Joseph's Hospital, West Bend, 10/02/2015
Hall, WA, Novel Prognostic Biomarkers of Response to Radiation Therapy in Adenocarcinoma of the Prostate, Radiation Oncology Grand Rounds, Froedtert & the Medical College of Wisconsin, 05/17/2016
Hall, WA, Personalized Radiation Therapy, Methods, Aims, Challenges, Clinical and Translational Science Research Seminar, Medical College of Wisconsin, 09/15/2016
Hall, WA, Colorectal Cancers, Southeastern Wisconsin Cancer Conference, Milwaukee, WI, 04/01/2017
Hall, WA, High Field MR Linac and STIM Trial, Gyn/Onc Grand Rounds, Medical College of Wisconsin, 02/15/2018
Hall, WA, Clinical Research Scholars Guest Facilitator, Clinical Research Scholars, Medical College of Wisconsin, 02/27/2018
Hall, WA, Preoperative Radiation Therapy for Pancreatic Adenocarcinoma, Personalizing an Optimal Dose and Fractionation Schedule, Pancreatic Symposium, Milwaukee, WI, 01/25/2019
Hall, WA, SBRT for Liver Malignancies, Resident SBRT Course, Webinar, 01/27/2021
Hall, WA, Productivity and Efficiency Techniques for Writing and Publishing, Medical College of Wisconsin, 08/09/2021
 
Regional
Hall, WA, Stereotactic Body Radiation Therapy versus Fractionated Therapy for Pancreatic Cancer, 6th Annual Medical College of Wisconsin Pancreatic Cancer Symposium, Milwaukee, WI, 01/27/2017
Hall, WA, Pre-Operative Radiation Therapy for Pancreatic Adenocarcinoma: When, Where, and How?, 7th Annual Pancreatic Symposium, Milwaukee, WI, 02/02/2018
Hall, WA, Changing Paradigms with Radiation Therapy - Is Total Neoadjuvant Therapy Optimal?, 2018 Annual GI Symposium, Kohler, WI, 05/04/2018
Hall, W, Updates on the MR-Enhance Trial, Bobby Nick Voss Charitable Foundation Presentation, Milwaukee, WI, 11/03/2020
Hall, W, Updates in Pancreatic Cancer Management at MCW, Fox 6 news Panel Interview, Milwaukee, WI, 11/18/2020
Hall, W, POP-RT , FLAME and FOLKMAN: Revisiting high-risk prostate cancer, MCW Rad Onc Grand Rounds, Milwaukee, WI, 06/09/2021
Hall, W, SBRT or fractionated therapy for pancreatic adenocarcinoma, the next frontier, ASCO 2021 Updates on Pancreatic Cancer, Virtual, 06/21/2021
 
National
Hall, WA, CRP and the Immune State of High Risk Prostate Cancer, NRG, Philadelphia, PA, 07/14/2017
Hall, WA, Clinical Prospects of a High Field MR-Linac, ASTRO, San Diego, CA, 09/23/2017
Hall, WA, Clinical Prospects of a High Field MR-Linac, RSNA, Chicago, IL, 11/27/2017
Hall, WA, Proposed Clinical Study for Rectal Adenocarcinoma, NRG, Phoenix, AZ, 01/26/2018
Hall, WA, NRG 0534, NRG Semiannual Meeting, Phoeniz, AZ, 02/08/2019
Hall, WA, Preoperative Radiation Therapy for Pancreatic Adenocarcinoma, Personalizing an Optimal dose and Fractionation Schedule, Society of Abdominal Radiology Disease-Focused Panels, 02/27/2019
Hall, WA, NRG Semiannual Meeting, Philadelphia, PA, 07/19/2019
Hall, WA, Presidential Symposium II-Treating Primary Site is Necessary in Curing Metastatic Disease, Annual ASTRO Meeting, Chicago, IL, 09/15/2019
Hall, WA, Palliative Pancreatic Radiation, ASTRO, Chicago, IL, 09/15/2019
Hall, WA, Mentoring, Annual ASTRO Meeting, Chicago, IL, 09/16/2019
Hall, WA, Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline Practical Radiation Oncology, ASTRO, Chicago, IL, 09/17/2019
Hall, WA, Safety and Feasibility of Dose Escalated Pelvic Lymph Node Intensity Modulated Radiation Therapy (IMRT) with A Simultaneous Hypofractionated Boost to the Prostate For High Risk Adenocarcinoma of the Prostate, a Prospective Phase II Clinical Trial, Annual ASTRO Meeting, Chicago, IL, 09/17/2019
Hall, WA, Initial Clinical Experience of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases, Primary Liver Malignancy, and Pancreatic Abdominal Recurrence with 4D-MRI based Online Adaptation and Real-Time MRI Monitoring using a 1.5 Tesla MR-Linac, Annual ASTRO Meeting, Chicago, IL, 09/18/2019
Hall, WA, Characterization of the Host Immuno-Inlammatory State in Response to Radiation Therapy and Correlation with Patient Reported Toxicities in Prostate Adenocarcinoma, ASTRO, Chicago, IL, 09/18/2019
Hall, WA, NRG Semiannual Meeting, Houston, TX, 01/10/2020
Hall, W, The role of SpaceOAR in the management of high risk prostate cancer, Plenary Session Pod Cast Interview, Virtual - University of California, San Francisco, 07/07/2020
Hall, WA, NRG Semiannual Meeting, Virtual, 07/17/2020
Hall, W, Neoadjuvant versus Peri-Operative Therapy for Pancreatic Cancer, GI ASCO 2021, Virtual, 12/03/2020
Hall, WA, Updates to the 2020 NRG Nodal Contouring Atlas, American College of Radiation Oncology (ACRO), American College of Radiation Oncology (ACRO) meeting 2021, Zoom, 02/25/2021
Hall, W, The SAMURAI trial, Discuss with GU Steering, NCI GU Steering Committee Presentation, Virtual, 04/21/2021
Hall, W, MR Guided Radiation Therapy, Practical Implications and Blue Sky Opportunities, Methodist University Hospital Grand Rounds, Memphis, TN, 06/23/2021
Hall, W, Updates to the JANUS Clinical Trial Desing, NCI Colorectal Steering Committee, NCI, Virtual-Washington DC, 08/16/2021
Hall, W, Updates to the SAMURAI Clincial trial Design, NCI GU Steering Committee, NCI, Virtual- Washington DC, 08/18/2021
Hall, W, Role of neoadjuvant RT in Pancreatic Adenocarcinoma, International Society of Gastrointestinal Oncology, Miami, FL, 10/01/2021
 
International
Dalah E, Tai A, Hall WA, Paulson E, Erickson B, Oshima K, Treatment Response Assessment with ADC for Chemoradiation of Pancreatic Carcinoma; Oral Presentation, MR in RT Symposium, Lund, Sweden, 2015
Hall, WA, MRL Consortium Meeting, Copenhagen, Denmark, 04/02/2019
Hall, WA, Overview of the MOMENTUM MR Linac data base, MR Consortium, Copenhagen, Denmark, 04/04/2019
Hall, WA, Pre-operative radiation therapy for pancreatic adenocarcinoma, MR Consortium, Copenhagen, Denmark, 04/05/2019
Hall, WA, MRL Consortium Meeting, Amsterdam, Netherlands, 10/29/2019
Hall WA, Overview and clinical indications treated on the Elekta Unity MR-Linac at Medical College of Wisconsin USA., Elekta Webinar, Online, 07/22/2020
Hall, W, Overview and Clinical Indications Treated on the Elekta Unity MR-linac at Medical College of Wisconsin, 1.5T MR Radiation Therapy Clinical Symposium, WebEx, Taiwan, 04/24/2021
Hall, W, Elekta Unity MR-Linac Launch Symposium Overview and Clinical Indications Treated on the Elekta Unity MR-linac at Medical College of Wisconsin, Elekta Unity MR-Linac Launch Symposium, WebEx, Korea, 04/29/2021
Hall, WA, Adaptive MR Guided Ablative RT for Abdominal Lymph Nodes, International Stereotacic Radiosurgery Society Meeting, Virtual, 11/08/2021
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Hall WA, Ali AN, Gullet N, Crocker I, Landry JC, Shu H, Prabhu RS, Curran WJ. Comparing CNS and Extra-CNS Hemangiopericytomas in the Surveillance, Epidemiology and End Results Program. Oral Presentation, 2011 American Society for Radiation Oncology 53rd Annual Meeting, Miami, FL, 10/02/2011 - 10/06/2011
Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Landry JC. Influence of Adjuvant Radiation Therapy Dose and Fractionation on Overall Survival in Resected Pancreatic Adenocarcinoma. Oral Presentation, 2012 American Society for Radiation Oncology 54th Annual Meeting, Boston, MA., 10/28/2012 - 10/31/2012
Hall WA, Nguyen C, Goodman M, Lipscomb J, Gillespie T. Health Related Quality of Life Outcomes Following Definitive Therapy Compared with Watchful Waiting in Patients with Localized Adenocarcinoma of the Prostate: An Analysis of the Atlanta Veterans Affairs Prostate Database. Oral Presentation, 2013 American Society for Radiation Oncology 55th Annual Meeting, Atlanta, GA., 09/22/2013 - 09/25/2013
Hall WA, Steuer CE, Nickleach DC, Behera M, Owonikoko TK, Higgins KA, Khuri FR, Curran WJ, Ramalingham SS. A Comparison of Palliative Inpatient Management Strategies for Cancer Related Superior Vena Cava Obstruction. Oral Presentation, 2014 American Society for Radiation Oncology 56th Annual Meeting, San Francisco, CA, 09/14/2014 - 09/17/2014
Hall WA, Pugh S, Wefel J, Armstrong T, Gilbert M, Brachman DG, Werner-Wasik M, Wendland M, Brown P, Chao ST, Roof K, Robins HI, Curran WJ Jr., Minesh M; Association of Neurocognitive and Patient Reported Outcomes with the Presence of Residual Disease Following Surgical Resection in Glioblastoma: Combined Secondary Analysis of NRG Oncology RTOG 0525 And 0825. Oral Presentation, Society for Neuro-Oncology, Miami, FL., 11/20/2014
Hall WA, Pugh SL, Gilbert MR, Wefel JS, Armstrong T, Wendland MM, Brachman DG, Roof KS, Brown PD, Crocker IR, Robins HI, Lee RJ, Chao ST, Kim L, Srkalovic G, Fisch BM Mehta MP, Curran WJ, Movsas B, Bevacizumab use in patients with subtotal resection of newly diagnosed glioblastoma (GBM): A secondary analysis of NRG Oncology/RTOG 0825, Oral Presentation, 2015 American Society for Radiation Oncology 57th Annual Meeting, San Antonio, TX, 10/21/2015
Watkins- Bruner D, Hall WA, NRG/RTOG 0415, Phase III Non-Inferiority Study Comparing 2 Fractionation Scheduled in Patients with Low Risk Prostate Cancer: Prostate Specific Quality of Life Results, Oral Presentation, 2016 American Society for Radiation Oncology 58th Annual Meeting, Boston, MA, 09/26/2016
Schott D, Hall WA, Paulson E, Erickson B, Oshima K, Dalah E, Schmidt T, Li XA, Correlation of ADC Texture with Treatment Response for Chemoradiation Therapy of Pancreatic Cancer., Oral Presentation, 2016 American Society for Radiation Oncology 58th Annual Meeting, Boston, MA, 09/27/2016
Hall WA, Pancreatic Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Radiomic Metrics Correlate with Pathologic Molecular Markers: An Exploratory Analysis, 51st Annual Pancreas Club Meeting: Poster of Distinction, Chicago, IL, 05/05/2017
Hall WA, Eastwood D, Kilari D, Van Wickle J, Raychaudhuri R, Borkenhagen J, See W, Lawton C, Androgen Deprivation Therapy (ADT) and Radiation Therapy (RT) Alone As Compared with Trimodality Therapy With ADT, RT, and Surgery In Men With High Risk, Non-Metastatic Adenocarcinoma Of The Prostate, American Society for Radiation Oncology 59th Annual Meeting, San Diego, CA, 09/24/2017
Hall WA, Karrison T, Rosenthal S, Amin M, Gomella L, Purdy J, Sartor O, Michalski J, Garzotto M, Bergom C, Jani A, Lawton C, Simko J, Moore J, Gore E, Lee W R, Nguyen P, Danielson B, Sandler H, Feng F, The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521, ASTRO/ BEST of ASTRO, 2018 American Society for Radiation Oncology 60th Annual Meeting, San Antonio, TX, 10/21/2018
Hall WA, Liu S, Fishbane N, Xu E, Davicioni E, Mahal B, Den R, Dess R, Jacksos W, Wong A, Schaeffer E, Karenes R, Carroll P, Nguyen P, Lawton C, Spratt D, Feng F, Development and Validation of Genomic Tools to Predict Extraprostatic Extension of Prostate Cancer, Opportunities for Personalizing Treatment, American Society for Radiation Oncology 60th Annual Meeting, San Antonio, TX, 10/23/2018
Hall, WA, Initial Clinical Experience of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases, Primary Liver Malignancy, and Pancreatic Abdominal Nodal Recurrence with 4D-MRI based Online Adaptation and Real-Time MRI Monitoring using a 1.5 Tesla MR-Linac, ASTRO, Chicago, IL, 09/18/2019
 
International
Hall, WA, Overview of Momentum Registry, MR Linac Consortium, Manchester, England, 03/2018
Hall WA, Grecula JC. Experience with the Mobetron Intraoperative Radiation Therapy Device at the Ohio State University. Oral Presentation, 2008 International Society for Intraoperative Radiation Therapy Conference, June 10-13, Madrid, Spain.
 

COMMITTEE SERVICE:
Medical College of Wisconsin
01/01/2018 - 01/01/2019 Advisor, Medical College Clinical and Translational Research Pathway Small Group Advisor
01/01/2019 - Present Ambassador, Cancer Center Ambassador Program
01/01/2019 - Present Faculty Member, g. Medical College Course Lecturer and Faculty member: “Current concepts in cancer biology”
01/01/2019 Advisor, Cancer Center and Medical College Advisory board for the Biomedical Imaging Shared Resource (BISR)
01/01/2020 - Present Grant Reviewer, Cancer Center Pilot Grant Review Committee
01/01/2020 - Present Grant Reviewer, American Cancer Society Institutional Grant Review Committee
04/01/2021 Member, Prostate Cancer Search Committee
 
Hospital
09/2014 - 09/2016 CME Committee - St. Joseph's Hospital, West Bend
09/2016 - Present Member, GI FRC Committee, Radiation Oncology, Medical College of Wisconsin
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
09/15/2016 Personalization of Radiation Therapy, Methods, Aims, Challenges
 
Resident and Fellow Education
01/06/2015 Radiobiology Class - Cell, Tissue and Tumor Kinetics
04/15/2015 Mock Oral Review, Radiation Oncology Resident Conference
07/28/2015 PET Directed Therapy for Early Favorable HL, Radiation Oncology Resident Journal Club
11/24/2015 Radio-Sensitivity and Cell Age in the Mitotic Cycle
12/01/2015 Fractionated Radiation and the Dose-Rate Effect
08/08/2016 Rectal Cancer Didactic
08/09/2016 Rectal Cancer Treatment Planning Didactic
10/31/2016 Anal Cancer
11/01/2016 Anal Cancer Treatment Planning
11/06/2016 Treatment Planning Prostate
11/22/2016 Hodgkin's Lymphoma
12/06/2016 Post-Op Prostate
02/07/2017 High Risk Prostate Cancer
03/01/2017 Bladder Cancer Treatment
04/24/2017 GI Mock Oral Boards Review
11/13/2017 Bladder Cancer Treatment
11/14/2017 Radiation Sensitivity and Cell Age in the Mitotic Cycle
11/21/2017 Fractionated Radiation and the Dose-Rate Effect
01/29/2018 Pancreas Treatment Planning
04/30/2018 GI Mock Oral Boards Review
 
Continuing Medical Education
02/08/2017 “The Evolving Role for Prostate Pelvic Nodal Radiation Therapy and Genomically Guided Radiation Therapy”
 

EXTRAMURAL TEACHING:
Resident and Fellow Education
08/11/2015 VA Medical Center, Resident planning conference, electron therapy skin cancer
09/16/2015 VA Medical Center, Head and neck unknown primary management
12/02/2015 VA Medical Center, Heterotopic Ossification and Keloids Management
01/20/2016 VA Medical Center, Management of Post-op Non-Small Cell Lung Cancer
02/17/2016 VA Medical Center, Extensive stage small cell lung cancer management
03/02/2016 VA Medical Center, Bladder Cancer Management
03/16/2016 VA Medical Center, Meningioma Management
04/06/2016 VA Medical Center, Thymoma Management
04/20/2016 VA Medical Center, GI Mock Oral Review Session
05/04/2016 VA Medical Center, Locally Advanced Non-Small Cell Lung Cancer
06/01/2016 VA Medical Center, Diffuse Large B-Cell Lymphoma Conference
09/21/2016 VA Medical Center, Intro to GI
11/02/2016 VA Medical Center, Bone Mets
12/07/2016 VA Medical Center, Benign CNS
04/19/2017 VA Medical Center, Rectal Cancer
02/07/2018 VA Medical Center, GI Review
 
Continuing Medical Education
02/02/2016 Medical College of Wisconsin: Radiation Therapy Students, Digestive System: Esophagus/ Stomach
02/09/2016 Medical College of Wisconsin: Radiation Therapy Students, Digestive System: Liver, Gallbladder, and Pancreas
02/13/2017 Medical College of Wisconsin: Radiation Therapy Students, Digestive System: Esophagus/ Stomach
02/20/2017 Medical College of Wisconsin: Radiation Therapy Students, Digestive System: Liver, Gallbladder, and Pancreas
 

HONOR SOCIETIES:
Alpha Omega Alpha Membership
Achievement Rewards for College Scientists, Chicago ARCS Foundation Scholar
Pi Mu Epsilon, National Mathematics Honors Society
Tau Beta PI, National Engineering Honors Society
Alpha Eta Mu Beta, National Biomedical Engineering Honors Society


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Vali FS, Nagda S, Hall WA, Sinacore J, Gao M, Lee SH, Hong R, Shoup M, Emami B. Comparison of Standardized Uptake Value - Based Positron Emission Tomography and Computed Tomography Target Volumes in Esophageal Cancer Patients Undergoing Radiotherapy. Int J Radiat Oncol Biol Phys, 2010:78(4): 1057 - 1063. PMID: 20199850
2. Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK. Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol. 2011;2011:979214. PMCID: PMC3263656
3. Prabhu RS, Liebman L, Wojno T, Hayek B, Hall WA, Crocker I. Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery. Radiat Oncol. 2012 Jun 19;7:95. PMCID: PMC3485155
4. Prabhu R, Shu HK, Hadjipanayis C, Dhabaan A, Hall WA, Raore B, Olson J, Curran WJ, Oyesiku N, Crocker I. Current Dosing Paradigm for Stereotactic Radiosurgery Alone After Surgical Resection Of Brain Metastases Needs to be Optimized for Improved Local Control. Int J Radiat Oncol Biol Phys, 2012; 83:e61-66. PMID: 22516387
5. Hall WA, Ali AN, Gullett N, Crocker I, Landry JC, Shu HK, Prabhu R, Curran W. Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature. Cancer. 2012 Nov 01;118(21):5331-8. PMID: 22517327
6. Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB. Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. J Am Coll Radiol. 2013 Feb;10(2):128-34. PMID: 23245437
7. Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I. Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Mar 01;85(3):643-9. PMID: 22836055
8. Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC. Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2013 May 01;86(1):102-7. PMID: 23290442
9. Prabhu RS, Dhabaan A, Hall WA, Ogunleye T, Crocker I, Curran WJ, Shu HK. Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases. J Neurooncol. 2013 May;113(1):93-9. PMID: 23440526
10. Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. Cancer. 2013 Jun 15;119(12):2350-7. PMCID: PMC3904231
11. Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. Cancer. 2013 Sep 01;119(17):3148-55. PMCID: PMC4389890
12. Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB. The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer. 2013 Sep 15;119(18):3272-9. PMID: 23818401
13. Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB. Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. Pract Radiat Oncol. 2013 Oct-Dec;3(4):e157-64. PMID: 24674413
14. Prabhu RS, Magliocca KR, Hanasoge S, Aiken AH, Hudgins PA, Hall WA, Chen SA, Eaton BR, Higgins KA, Saba NF, Beitler JJ. Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. Int J Radiat Oncol Biol Phys. 2014 Jan 01;88(1):122-9. PMID: 24331658
15. Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer. 2014 Feb 15;120(4):499-506. PMCID: PMC4380170
16. Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. J Gastrointest Oncol. 2014 Apr;5(2):77-85. PMCID: PMC3999628
17. Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS. CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. Cancer Res. 2014 May 15;74(10):2677-87. PMCID: PMC4025946
18. Prabhu RS, Hanasoge S, Magliocca KR, Moeller BJ, Milas ZL, Hall WA, El-Deiry M, Wadsworth JT, Higgins KA, Beitler JJ. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. Cancer. 2014 May 15;120(10):1499-506. PMID: 24510454
19. Hall WA, Prabhu RS, Crocker I, Dhabaan A, Jiang X, Curran WJ, Kandula S, Oguleye T, Shu HG. Repeat Whole Brain Radiation Therapy with a Simultaneous Infield Boost: A Novel Technique for Reirradiation. Journal of Radiotherapy, vol. 2014, Article ID 403945, 8 pages, 2014. https://doi.org/10.1155/2014/403945.
20. Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. Int J Radiat Oncol Biol Phys. 2014 Jun 01;89(2):360-9. PMID: 24837891
21. Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. Oncogene. 2014 Nov 20;33(47):5450-6. PMID: 24276239
22. Dulaney C, Hall WA, Mikell JL, Pittal PM, Prabhu RS, Kooby DA, Hanley K, Sarmiento JS, Landry JC. The Influence of Time Interval Between Abdominal MRI Acquisition and Operative Date on Radiographic to Pathologic Size Discrepancy in Pancreatic Adenocarcinoma: Implications for Local Therapy. Journal of Biomedical Graphics and Computing. ePub Vol 4, No2, 2014. DOI: 10.5430/jbgc.v4n2p15
23. Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. J Thorac Oncol. 2015 Mar;10(3):462-71. PMCID: PMC4336617
24. Cheng J, Squires MH, Mikell JL, Fisher SB, Staley CA, Kooby DA, Curran WJ, Hall WA, Colbert LC, Shelton JW, Maithel SK, Landry JC, Yu D. Radiotherapy Patterns Of Care in Gastric Adenocarcinoma: A Single Institutional Experience. J Gastrointest Oncol. 2015 Jun;6(3):247-53 PMCID: PMC4397246
25. Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck. 2015 Jun;37(6):777-82. PMID: 24596123
26. Tanenbaum DG, Hall WA, Mittal P, Nickleach D, Mikell JL, Colbert LE, Moreno CC, Squires MH, Fisher SB, Yu DS, Kooby DA, Maithel SK, Landry JC. Cholangiocarcinoma Size on MRI Versus Pathologic Specimen: Implications for Radiation Treatment Planning. Pract Radiat Oncol. 2016 May-Jun;6(3) PMID: 26979545
27. Seldon CS, Colbert LE, Hall WA, Fisher SB, Yu DS, Landry JC. Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol. 2016 Apr 15;8(4):358-65. PMID 27096031.
28. Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS. TNFRSF10C copy number variation is associated with metastatic colorectal cancer. J Gastrointest Oncol. 2016 Jun;7(3):306-14. PMCID: PMC4880759
29. Lee WR, Dignam JJ, Amin M, Bruner D, Low D, Swanson GP, Shah AB, D’Souza DP, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria S, Chen Y, Koontz BF, Paulus R, and Sandler HM. NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of Clinical Oncology, 2016 Jul 10;34(20):2325-32 PMID: 27044935
30. Heerkens HD, Hall WA, Li X.A, Knechtges P, Dalah E, Paulson ES, Vanden Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, Van Vulpen K, Erickson BA: Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiotherapy of pancreatic cancer. Pract Radiat Oncol. 2017 Mar - Apr;7(2):126-136. PMID: 28089481
31. Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA. Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. PLoS One. 2017;12(6):e0178961. PMCID: PMC5456365
32. Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY. Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. Semin Radiat Oncol. 2017 01;27(1):11-20. PMID: 27986207
33. Chen X, Oshima K, Schott D, Hall WA, Erickson B, Knechtges P, Wu H, Song YQ, Tao YL, Li DJ, Zheng C, Li XA; Assessment of Treatment Response During Chemoradiation Therapy for Pancreatic Cancer Based on Quantitative Radiomic Analysis of Daily CTs: An Exploratory Study; PLOS ONE; 2017 Jun 2; PMCID:PMC5456365
34. Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Cancer. 2017 Sep 15;123(18):3486-3493. PMCID: PMC5589506
35. Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? J Gastrointest Surg. 2017 Nov;21(11):1793-1803. PMID 28849366
36. Van Wickle JD, Paulson ES, Landry JC, Erickson BA, Hall WA. Adaptive radiation dose escalation in rectal adenocarcinoma: a review. J Gastrointest Oncol. 2017 Oct;8(5):902-914. PMCID: PMC5674246
37. Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall WA, Erickson B, Evans DB, Christians KK. Locally advanced pancreas cancer: Staging and goals of therapy. Surgery. 2018 May;163(5):1053-1062. PMID: 29331400
38. Koay EJ, Hall WA, Park PC, Erickson B, Herman JM. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol (NY). 2018 Feb;43(2):393-403 PMCID: PMC5832555
39. Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ Jr, Movsas B. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. Neurosurgery. 2018 Mar 30. PMID: 29618054
40. Hall WA, Heerkens HD, Paulson ES, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA. Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference. Pract Radiat Oncol. 2018 Mar - Apr;8(2):107-115. PMID: 29426692
41. Dalah E, Erickson B, Oshima K, Schott D, Hall WA, Paulson E, Tai A, Knechtges P, Li XA. Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. Transl Oncol. 2018 Apr;11(2):391-398. PMCID: PMC5852406
42. Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 Jul 9. PMID: 29984547
43. Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA. Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. Neurosurgery. 2018 May 01;82(5):595-603. PMID: 29669114
44. Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS. Optimized -value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. J Med Imaging (Bellingham). 2018 01;5(1):011004. PMCID: PMC5658575
45. Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. Int J Radiat Oncol Biol Phys. 2018 Jun 01;101(2):274-284. PMID: 28964588
46. Dalah E, Tai A, Oshima K, Hall WA, Erickson B, Li XA. PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study. Transl Oncol. 2018 Jul 13;11(5):1104-1109. PMCID: PMC6070701
47. Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst. 2018 May 1;110(5):460-466. PMID 29165692
48. Koay EJ, Hall W, Park PC, Erickson B, Herman JM. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol (NY). 2018 02;43(2):393-403. PMCID: PMC5832555
49. McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS. Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 08 01;101(5):1179-1187. PMCID: PMC6190585
50. Barnes CA, Tsai S, Hall WA, Erickson BA, Evans DB. Neoadjuvant chemoradiation for operable pancreatic cancer: The importance of local disease control Pancreatic Cancer. 11 April 2018:1219-1237.
51. Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK. Locally advanced pancreas cancer: Staging and goals of therapy. Surgery. 2018 05;163(5):1053-1062.
52. Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA. Imaging predictors of treatment outcomes in rectal cancer: An overview. Crit Rev Oncol Hematol. 2018 Sep;129:153-162. PMID 30097234
53. Kerns SL, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B. Radiation biology and oncology in the genomic era. Br J Radiol. 2018 Nov;91(1091):20170949. PMCID: PMC6475928
54. Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan AH, Mackinnon AC, Tolat P, Ahmad AS, Hall WA Erickson BA, Evans DB. A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg. 2018 Oct;268(4):610-619. PMID: 30080723
55. Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. Ann Surg. 2018 Oct 11. PMID: 30312198
56. Hall, W; Straza, M; Chen, X; Mickevicius, N; Erickson, B; Schultz, C; Ahunbay, E; Li, A; Paulson, E; "Initial Clinical Experience of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases, Primary Liver Malignancy, and Pancreatic Abdominal Nodal Recurrence with 4D-MRI based Online Adaptation and Real-Time MRI Monitoring using a 1.5 Tesla MR-Linac" 2/24/2019. IN PRESS.
57. Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B. Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2019 May 01;5(5):664-670. PMCID: PMC6459051
58. Hall WA, Goodman KA. Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. Radiat Oncol. 2019 Jun 26;14(1):114. PMCID: PMC6595558
59. Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM. Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. Radiother Oncol. 2019 12;141:137-143. PMCID: PMC6912855
60. Lorenz JW, Schott D, Rein L, Mostafaei F, Noid G, Lawton C, Bedi M, Li XA, Schultz CJ, Paulson E, Hall WA. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer. Cureus. 2019 Apr 20;11(4):e4510. PMCID: PMC6590865
61. Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium. The transformation of radiation oncology using real-time magnetic resonance guidance: A review. Eur J Cancer. 2019 11;122:42-52. PMCID: PMC8447225
62. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery. 2019 09;166(3):277-285.
63. Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S. Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? J Gastrointest Surg. 2020 02;24(2):235-242.
64. Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA. Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. J Natl Compr Canc Netw. 2019 07 01;17(7):829-837.
65. Mostafaei F, Tai A, Omari E, Song Y, Christian J, Paulson E, Hall W, Erickson B, Li XA. Variations of MRI-assessed peristaltic motions during radiation therapy. PLoS One. 2018;13(10):e0205917. PMCID: PMC6201905
66. ShreeMahadevan L, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, Triest B, Krishnan S, Hall W. Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]. Crit Rev Oncol Hematol. 2019 02;134:71.
67. Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2019 Sep - Oct;9(5):322-332.
68. Schott D, Schmidt TG, Hall W, Knechtges P, Noid G, Klawikowski S, Erickson B, Li XA. Estimation of changing gross tumor volume from longitudinal CTs during radiation therapy delivery based on a texture analysis with classifier algorithms: a proof-of-concept study. Quant Imaging Med Surg. 2019 Jul;9(7):1189-1200. PMCID: PMC6685807
69. Zhang, Y; Paulson, E; Lim, S; Hall, W; Ahunbay, E; Mickevicius, N; Straza, M; Erickson, B; Li, X Allen; "A patient-specific auto-segmentation strategy using multi-input deformable image registration for MRI-guided online adaptive radiotherapy: a feasible study" In Press. 2020.
70. Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B. Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. Pract Radiat Oncol. 2020 Nov - Dec;10(6):e495-e507. PMCID: PMC7423616
71. Lukovic J, Henke L, Gani C, Kim TK, Stanescu T, Hosni A, Lindsay P, Erickson B, Khor R, Eccles C, Boon C, Donker M, Jagavkar R, Nowee ME, Hall WA, Parikh P, Dawson LA. MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology. Int J Radiat Oncol Biol Phys. 2020 03 15;106(4):743-753.
72. Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. JAMA Oncol. 2020 05 01;6(5):735-743. PMCID: PMC7189892
73. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer HPB. 2020.
74. Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S. Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. Front Oncol. 2020;10:460. PMCID: PMC7175033
75. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer Surgery (United States). 2020.
76. Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S. Total Neoadjuvant Therapy for Operable Pancreatic Cancer. Ann Surg Oncol. 2021 Apr;28(4):2246-2256.
77. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. Surgery. 2020 09;168(3):440-447.
78. Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY. Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer. Surgery. 2021 03;169(3):629-635.
79. Hall WA, Sabharwal L, Udhane V, Maranto C, Nevalainen MT. Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy. Int J Biochem Cell Biol. 2020 10;127:105827.
80. Kooreman ES, van Houdt PJ, Keesman R, Pos FJ, van Pelt VWJ, Nowee ME, Wetscherek A, Tijssen RHN, Philippens MEP, Thorwarth D, Wang J, Shukla-Dave A, Hall WA, Paulson ES, van der Heide UA. ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium. Radiother Oncol. 2020 12;153:106-113. PMCID: PMC8327388
81. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. Front Oncol. 2020;10:1328. PMCID: PMC7505056
82. Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 01 01;109(1):174-185. PMCID: PMC7736505
83. Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. PLoS One. 2020;15(8):e0236570. PMCID: PMC7413561
84. Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F. Development and validation of a genomic tool to predict seminal vesicle invasion in adenocarcinoma of the prostate JCO Precision Oncology. 2020;4:1228-1238.
85. Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. Am J Surg. 2021 07;222(1):10-17.
86. Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA. A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging-Guided Online Adaptive Radiation Therapy: A Feasibility Study. Adv Radiat Oncol. 2020 Nov-Dec;5(6):1350-1358. PMCID: PMC7718500
87. Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR. Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage. Clin Genitourin Cancer. 2021 06;19(3):267-270.e1.
88. Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF. Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. Pract Radiat Oncol. 2021 Nov-Dec;11(6):527-533.
89. Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C. The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? Clinical and Translational Radiation Oncology. May 2021;28:124-128.
90. Feng FY, Huang HC, Spratt DE, Zhao SG, Sandler HM, Simko JP, Davicioni E, Nguyen PL, Pollack A, Efstathiou JA, Dicker AP, Todorovic T, Margrave J, Liu YS, Dabbas B, Thompson DJS, Das R, Dignam JJ, Sweeney C, Attard G, Bahary JP, Lukka HR, Hall WA, Pisansky TM, Shah AB, Pugh SL, Shipley WU, Tran PT. Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial. JAMA Oncol. 2021 04 01;7(4):544-552. PMCID: PMC7879385
91. Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA. Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. Neurosurgery. 2018 05 01;82(5):595-603.
92. Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C. The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? Clin Transl Radiat Oncol. 2021 May;28:124-128. PMCID: PMC8085778
93. van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA. Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group European Journal of Cancer. August 2021;153:64-71.
94. Nasief H, Zheng C, Schott D, Hall W, Tsai S, Erickson B, Allen Li X. A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. NPJ Precis Oncol. 2019;3:25. PMCID: PMC6778189
95. Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Front Oncol. 2021;11:628155. PMCID: PMC8144850
96. Hall WA, Erickson B, Crane CH. Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer. Surg Oncol Clin N Am. 2021 Oct;30(4):719-730. PMCID: PMC8462521
97. Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS. Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. Cancer Metastasis Rev. 2021 Sep;40(3):879-889.
98. van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA. Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. Eur J Cancer. 2021 08;153:64-71. PMCID: PMC8340311
99. Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, Moxley KM, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021 Aug 01;7(8):1225-1230. PMCID: PMC8251652
100. Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA. Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. Pract Radiat Oncol. 2021 Nov-Dec;11(6):453-459.
101. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM, MR-Linac Consortium. Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. Int J Radiat Oncol Biol Phys. 2021 11 15;111(4):867-875.
102. Beinhoff P, Sabharwal L, Udhane V, Maranto C, LaViolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT. Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? Cancers (Basel). 2021 Oct 17;13(20). PMCID: PMC8533841
 
Books, Chapters, and Reviews
1. Hall WA, Curran W. Central Nervous System Tumors. Technical Basis of Radiation Therapy: Practical Clinical Applications. Seymour Levitt, James A Purdy, Carlos Perez, Philip Poortmans. Springer, Heidelberg Germany, 2012
2. Hall WA, Prabhu R, Staley C, Landry JC. The Role of Radiation Therapy in the Management of Non-Metastatic Rectal Cancer: Early and Locally Advanced Disease. Cancers of the Colon and Rectum: A Multidisciplinary Approach to Diagnosis and Management. Editors: Al Benson, Bapsi Chakravarthy, Stan Hamilton and Elin Sigurdson, 2012
3. Hall WA, Heerkens HD, Paulson EA, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA. Pancreatic Gross Tumor Volume Contouring on Computed Tomography as Compared with MRI, Results of an International MRI Consensus Contouring Conference. PhD thesis Text Book, Hanne Heerkens, Utrecht University, the Netherlands, Utrecht 2017. Chapter 8: pp 147-160. ISBN 978-90-393-6842-8
4. Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GI, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BE. Recommendations for MRI-based contouring of gross tumor volume and organs a risk for radiation therapy of pancreatic cancer in Towards online MRI guided radiotherapy for pancreatic cancer. PhD thesis Text Book, Hanne Heerkens, Utrecht University, the Netherlands, Utrecht 2017. Chapter 7: pp 125-144, ISBN 978-90-393-6842-8
5. Barnes CA, Erickson B, Hall WA, Evans D, Tsai S; Neoadjuvant Chemoradiation for Operable Pancreatic Cancer: The Importance of Local Disease Control; Springer 2018; The Importance of Local Disease Control. Springer Science Business Media LLC, 233 Spring Street, New York, NY 10013, U.S.A. (2017); 1-20. 10.1007/978-1-4939-6631-8_95-1.
 
Editorials, Letters to Editor, Other
1. Hall, WA, Torres MT. Commentary On: "Irradiation Effect After Mastectomy on Breast Cancer Recurrence in Patients Presenting with Locally Advanced Disease" Breast Diseases: A Year Book Quarterly Vol 23, No. 2, July - September 2012.
2. Hall WA, Erickson B; Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly; JOP; April 10, 2017 from 141.106.128.044
3. Kishan AU, Hall WA, Spratt DE. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? Eur Urol. 2019 05;75(5):e133-e134.
4. Hall WA. Opportunities and Challenges of Genomically Guided Decision Making for Patients With Prostate Cancer. Pract Radiat Oncol. 2020 Mar - Apr;10(2):93-94.
5. Hall WA, Tree AC, Dearnaley D, Parker CC, Prasad V, Roach M 3rd, Lawton CAF. Considering benefit and risk before routinely recommending SpaceOAR. Lancet Oncol. 2021 01;22(1):11-13.
6. Hall WA, Lawton CAF, coauthors. In Reply to Onal et al. Int J Radiat Oncol Biol Phys. 2021 06 01;110(2):620-621.
7. Hall WA, Dawson LA, Hong TS, Palta M, Herman JM, Evans DB, Tsai S, Ferrone CR, B Fleming J, Chang DT, Crane C, Koong AC, Oar A, Parikh P, Erickson B, Hoffe S, Goodman KA. Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. J Clin Oncol. 2021 Dec 01;39(34):3773-3777. PMCID: PMC8608256
 
Abstracts
1. Iyengar R, Hall WA, Henderson K, Russell B, Samarel A. Stretch-Induced Akt Phosphorylation/Dephosphorylation In Cardiac Myocytes. Federation of American Societies for Experimental Biology (FASEB) J 21:908.28, 2007.
2. Hall WA, Senthi A, Nagda S, Love R. Importance of Image Guided Patient Setup in Stereotactic Body Radiation Therapy (SBRT) of Early Stage NSCLC. American Society for Radiation Oncology, 2008 Multidisciplinary Symposium in Thoracic Oncology. Abstract #155, poster presentation.
3. Grecula JC, Hall WA, Hoang T, Mayr N, Ross P. Modulation of Radiation Response of Head and Neck Cancer Cells with Poly (ADP-Ribose) Polymerase Inhibitor-ABT 888, International Journal of Radiation Oncology Biology, Physics, Sep 2008, Vol 72.
4. Hall WA, Wang L, Clarke J, Otterson G. Modulation of Radiation Response of Non-Small Cell Lung Cancer Cells with Poly (ADP-Ribose) Polymerase Inhibitor: ABT-888, International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology, Sep 2008, Vol 72.
5. Vali F, Hall WA, Gao M. Inter-Fraction 3-Dimensional Variations/Motion/Shifts of Hotspots in the Bladder and Rectum During CT-Guided HDR Brachytherapy of the Cervix: Are We Over Estimating the Dose to the Organs at Risk? International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology, Sep 2008, Vol 72.
6. Hall WA, Chen Z, Jiang X, Dhabban A, Crocker I. Safety and Efficacy of Fractionated Stereotactic Radiotherapy and Stereotactic Radiosurgery in the Treatment of Functioning and Non-Functioning Pituitary Tumors. American Society for Radiation Oncology 2010, International Journal of Radiation Oncology, Biology, Physics, Vol 78 (3) S289.
7. Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB. Treatment of Efficiency of Volumetric Modulated Arc Therapy (VMAT in Comparison to Intensity Modulated Radiotherapy (IMRT) in the Treatment of Prostate Cancer. American Society for Radiation Oncology 2011, International Journal of Radiation Oncology, Biology, Physics, Vol 81 S2.
8. Hall WA, Ali AN, Gullet N, Crocker I, Landry JC, Shu H, Prabhu RS, Curran WJ. Comparing CNS and Extra CNS Hemangiopericytomas in the Surveillance, Epidemiology and End Results Program, an Analysis of 655 Patients. American Society for Radiation Oncology 2011, International Journal of Radiation Oncology, Biology, Physics, Vol 81 S2.
9. Hall WA, Rossi PJ, Godette K, Jani AB. Improvement in Acute GI and GU Toxicities with the Use of Volume Modulated Arc Therapy (VMAT) in the Treatment of Adenocarcinoma of the Prostate. American Radium Society, 2012. Poster presentation.
10. Hall WA, Rossi PJ, Cooper S, Master VA, Jani AB. C-Reactive Protein (CRP): Initial Exploratory Study of an Inflammatory Biomarker for Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology 2012 Poster Presentation.
11. Prabhu R, Shu HK, Hadjipanayis C, Dhabaan A, Hall W, Raore B, Olson J, Curran W, Oyesiku N, Crocker I. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control. Int J Radiat Oncol Biol Phys. 2012 May 01;83(1):e61-6.
12. Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Landry JC. Influence of Adjuvant Radiation Therapy Doses and Fractionation on Overall Survival for Pancreatic Adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics, American Society for Radiation Oncology 2012.
13. Mikell J, Hall WA, Mittal P, Prabhu RS, David K, Hanley K, Colbert LE, Landry JC. Tumor Size on Abdominal MRI Versus Pathologic Specimen in Resected Pancreatic Adenocarcinoma: Implications for Radiotherapy Planning. International Journal of Radiation Oncology, Biology, Physics. Digital poster discussion American Society for Radiation Oncology 2012.
14. Colbert LE, Hall WA, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Landry JC. Radiation Therapy Sequencing for Resected Pancreatic Adenocarcinoma. ASCO GI Cancers Symposium, San Francisco CA, January 24-26, 2013.
15. Hall WA, Nickleach DN, Switchenko J, Lipcomb J, Goodman M, Ward KC, Gillespie T. The Use of Radiation Therapy for Adenocarcinoma of the Prostate in Rural Georgia: A population Based Analysis. ASCO GU Cancers Symposium, January 16-18, 2014.
16. Hall WA, Pugh S, Wefel J, Armstrong T, Gilbert M, Brachman D, Werner-Wasik M, Wendland M, Brown P, Chao S, Roof K, Robins H, Curran W, Mehta M; Association of Neurocognitive and Patient Reported Outcomes with the Presence of Residual Disease Following Surgical Resection of Glioblastoma: Combined Secondary Analysis of NRG Oncology RTOG 0525 and 0825; Society for Neuro-Oncology; Oral Presentation; 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology; Miami, FL; November, 2014
17. Dalah E, Oshima K, Hall WA, Erickson B. PET-Based Treatment Response Assessment for Neoadjuvant Chemoradiation for Pancreatic Adenocarcinoma. Annual Meeting of the American Association of Physicists in Medicine, Anaheim, CA, July 12-16, 2015.
18. Dalah E, Oshima K, Hall WA, Knechtges P, Erickson B, Li XA; Correlation of CT Numbers with Radiation Treatment Response for Pancreatic Cancer; American Association of Physicists in Medicine Annual Meeting Poster Presentation; Anaheim, California; July, 2015
19. Chen XV, Zhang J, Dalah E, Liu F, Hall WA, Erickson. Change of CT Number During the Course of Chemoradiation Therapy for Pancreatic Cancer. Poster presentation at the Annual Meeting of the American Association of Physicists in Medicine in Anaheim, CA, July 12-16, 2015.
20. Paulson E, Hall WA, Robbins J; Feasibility of Diffusion Weighted MR Lymphography for Cervical Lymph Node Delineation in Head and Neck Cancer; American Society for Radiation Oncology Oral Presentation; San Antonio, TX, September, 2015
21. Dalah E, Tai A, Oshima K, Paulson ES, Hall WH, Erickson BA, Li A. Correlation of ADC with Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. Poster presentation at the American Society for Radiation Oncology 57th annual meeting, San Antonio, TX, October 18-21, 2015.
22. Hall WA, Pugh SL, Gilbert MR, Wefel JS, Armstrong T, Wendland MM, Brachman DG, Roof KS, Brown PD, Crocker IR, Robins HI, Lee RJ, Chao ST, Kim L, Srkalovic G, Fisch BM, Mehta MP, Curran WJ, Movsas B. Benvacizumab use in Patients with Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825. Oral presentation at the American Society for Radiation Oncology 57th annual meeting, San Antonio, TX, October 18-21, 2015
23. Paulson E, Hall WA, Robbins J. Feasibility of Diffusion Weighted MR Lymphography for Cervical Lymph Node Delineation in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2015 Nov:93 (3), E604.
24. Chen X, Schott D., Song Y, Hall WA, Erickson B, Li XA. Radiation-Induced Changes in CT Number Histogram During Chemoradiation Therapy for Pancreatic Cancer, June 2016, Medical Physics. American Association of Physicists in Medicine.
25. Schott D,T, Schmidt, X, Chen, S. Klawikowski, G. Hall, WA, Noid, E, Dalah, X, Li, A. Statistical Segmentation On Quantitative CT for Assessing Spatial Tumor Response During Radiation Therapy Delivery, American Association of Physicists in Medicine Annual Meeting and Exhibition, Washington, DC, July 31 – August 4, 2016
26. Moningi S, Amer A, Hall WA, Erickson B, Varadhachary GR, Das P, Taniguchi CM, Fleming JB, Katz M, Crane CH,Koay EJ; A Computed Tomography Imaging Picture of Pancreatic Cancer as a Predictive Biomarker for Escalated Dose Radiation Therapy; American Society for Radiation Oncology; Poster Presentation; Boston, MA, September, 2016
27. Hall, WA, Lans, D, Erickson, B, Gore, E, Arce-Lara, C, Kelley, M, Santana-Davila, R, Marcus, D, Tsai, S, Ridolfi, T; Outcome Analysis of Treatment in Stage IIA T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA); Poster Presentation, 2016 American Society for Radiation Oncology 58th Annual Meeting; Boston, MA; September, 2016
28. Hall, WA, Paulson, E, Erickson, B, Li, X, Vicstocky, A, Tsai, S, Koay, E, Knechges, P, Evans, D, Christian, K, Ritch, P, Geroge, B, Oshima, K; Pancreatic Magnetic Resonance Imaging (MRI) and Computer Tomography (CT) Radiomic Metrics Correlate with Pathologic Molecular: An Exploratory Analysis; Poster Presentation, 2016 American Society for Radiation Oncology 58th Annual Meeting; Boston, MA; September, 2016
29. Watkins Bruner D, Pugh SL, Lee WR, Dignam JJ, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, Sandler HM, Movsas B. NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S2-S3.
30. Schott D, Hall WA, Gilat Schmidt T, Dalah E, Oshima K, Paulson ES, Knechtges PM, Erickson BA, Li A. Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S70.
31. Blitzer G, Hall WA, Tsai S, Aldakkak M, Hellman R, Evans D, Christians K, George B, Ritch P, Erickson B; Should Functional Renal Scans be Obtained Prior to Upper Abdominal Radiation for Pancreatic Cancer?; DOI: 10.1200/JCO.2017.35.4_suppl.442 Journal of Clinical Oncology 35, no. 4_suppl (February 1 2017) 442-442; Presented as a poster at the 2017 Gastrointestinal Cancers Symposium in San Francisco, California from January 19-21, 2017.
32. Colbert LE, Dharmarajan KV, Switchenko J, Taniguchi CM, Hall WA, Gillespie TW, Kooby DA, Lipscomb J, Landry JC. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S195.
33. Hall WA; Pancreatic Magnetic Resonance Imaging (MRI) and Computer Tomography (CT) Radiomics Metrics Correlate with Pathologic Molecular Markers: An Exploratory Analysis; 51st Annual Pancreas Club Meeting; Poster Presentation; Chicago, IL; February, 2017
34. Chen XF, Prior P, Hall WA, Erickson E, Herman J, Li XA; An Analysis on Local Control of Chemoradiotherapy for the use of the Locally Advanced Pancreatic Cancer Using a Bio-Physical Model; American Society for Radiation Oncology; Oral Presentation, San Diego, CA; September, 2017; Int J Radiat Oncol Biol Phys 2017, 99(2S)S166
35. Hall, WA, Heerkens, H, Paulson, E, Meijer, G, Kotte, A, Knechtges, P, Parikh, P, Bassetti, M Lee, P, Aitken, K, Palta, M, Myrehaug, S, Koay, E, Portelance, L, Ben-Josef, E, Erickson, B; Pancreatic Adenocarcinoma Gross Tumor Volume Contouring On Computed Tomography (CT) As Compared With Magnetic Resonance Imaging (MRI), Results Of An International Consensus Contouring Conference; Int J Radiat Oncol Biol Phys, September, 2017
36. Hall, WA, Eastwood, D, Kilari, D, Van Wickle, J, Raychaudhuri, R, Borkenhagen, J, See, W, Lawton, C; Androgen Deprivation Therapy (ADT) and Radiation Therapy (RT) Alone As Compared with Trimodality Therapy With ADT, RT, and Surgery In Men With High Risk, Non-Metastatic Adenocarcinoma Of The Prostate; Int J Radiat Oncol Biol Phys, September, 2017
37. Borkenhagen J, Lawton C, Eastwood D, Kilari D, See W, Van Winkle JD, Hall WA; Prognostic value of clinical stage T2 substages in prostate cancer: A national cancer database review; American Society for Radiation Oncology; San Diego, CA; 9/2017; Poster
38. Mostafaei F, Tai A, Paulson E, Hall WA, Erickson BE, Li XA; Quantifying complex abdominal organ motions in different time frames in radiation therapy; American Society for Radiation Oncology; San Diego, CA; 9/2017; Poster
39. Chen XV, Schott D, Hao Y, Hall WA, Erickson B, Oshima K, Li XA; A quantitative analysis on CT histogram features before chemoradiation therapy for pancreatic cancer; American Society for Radiation Oncology; San Diego, CA; 9/2017; Poster
40. Schott, Hall WA, Paulson E, Erickson B, Oshima K, Knechtges P, Li XA; Treatment Response Assessment Using Quantitative DCE MRI for Chemoradiation Therapy of Pancreatic Cancer; American Society for Radiation Oncology; e-poster presentation; San Diego, CA; September, 2017; Int J Radiat Oncol Biol Phys 2017, 99(2S)S195.
41. Saeed H, Cheng H, Aldakkak M, Tsai S, Evans DB, Christians K, Thomas J, George B, Ritch P, Wittmann D, Hall WA, Erickson B. Neoadjuvant Chemoradiation with IMRT for Pancreatic Cancer is associated with Minimal Toxicity without compromising Local Control. Poster presentation at American Society for Radiation Oncology 59th annual meeting, San Diego, CA. September 24-27, 2017.
42. Schoot D, Hall WA, Chen XV, Klawikowski S, Noid G, Erickson B, Knechtges P, Gilat Schmidt T, Li XA; Machine Learning and Texture Analysis for Assessing Spatial Tumor Response Based on Daily CTs During Radiation Therapy for Pancreatic Adenocarcinomas; American Association of Physicists in Medicine; Poster Presentation, 2017
43. Van Wickle J.D, Rein L, Smith E, Berger N.G, Gamblin T.C, George G, Ritch P, Yen T, Tsai S, Christians K, Evans D.B, Robbins J.R, Erickson B.A, Hall WA; Sequencing of Chemotherapy and Radiation Therapy in the Treatment of Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma; Nov, 2017; 103rd Annual RSNA; Chicago, IL; SSJ24-05
44. George T, Rea W, Yothers G, Hong T, Russell M, You YN, Pogue-Geile K, Gollub M, Hall WA, Rahma O, Kachnic LA, Parker W, Jacobs S, Wolmark N; NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer; 2018 Gastrointestinal Cancers Symposium; January 2018, San Diego, CA
45. Nasief H, Hall WA, Schott D, Klawikowski S, Erickson B, Zheng C; Delta Radiomics of Daily CTs Acquired During Chemoradiation Therapy of Pancreatic Cancer; American Association of Physicists in Medicine, Oral Presentation; Nashville, TN; July, 2018
46. Mostafaei F, Tai A, Paulson E, Hall WA, Erickson B, Liu Q, Li XA; Inter and Intra Patient Peristaltic Motion Assessed with Cine MRI; American Society for Radiation Oncology, e-Poster, San Antonio, TX; October, 2018
47. Kinchen CL, Zhang U, Hall WA, Erickson B, Li XA; Characterizing Interfraction Variation of Separation between Pancreas and Duodenum During Radiotherapy of Pancreatic Cancer for Online Adaptive Replanning; American Society for Radiation Oncology; e-Poster Presentation, San Antonio, TX; October, 2018
48. Fain R, Lorenz J, Chen XV, Li A, Erickson B, Hall WA; The Unity of Position Emission Tomography (PET) to Guide Radiation Therapy Target Volume Determination as Compared with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) for Rectal Cancer; American Society for Radiation Oncology; e-Poster Presentation; San Antonio, TX; October, 2018
49. Prior P, Chen X, Hall WA, Erickson B, Li XA; Estimation of the Alpha-Beta Ratio for Chemoradiation of Locally Advanced Pancreatic Cancer; American Society for Radiation Oncology; Oral Presentation; San Antonio, TX; October, 2018
50. Hall WA; Liu S, Fishbane N, Xu M, Daviciono E, Mahal B, Den R, Dess R, Jackson W, Wong A, Schaeffer E, Karnes R, Carroll P, Nguyen P, Lawton C, Spratt D, Feng F; Development and Validation of Genomic Tools to Predict Extraprostatic Extension of Prostate Cancer, Opportunities for Personalizing Treatment; American Society for Radiation Oncology; Oral Presentation 200; San Antonio, TX; October, 2018
51. Hall WA, Karrison T, Rosenthal S, Amin M, Gomella L, Purdy J, Sator O, Michalski J, Garzotto M, Bergom C, Jani A, Lawton C, Simko J, Moore J, Gore E, Robert Lee W, Nguyen P, Danielson B, Sandler H, Feng F; The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521; American Society for Radiation Oncology; Oral Presentation 25; San Antonio, TX; October, 2018
52. Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.
53. Mickevicius, N; Straza, M; Hall, W; Paulson, E; "First Clinical Use of 4D-MRI for Online Adaptive MR-gRT on a High Field MR-Linac" 2/22/2019. In Press
54. Hall, W; Bedi, M; Kilari, D; Bylow, KA; Burfeind, J; See, W; Straza, MW; Lawton, CAF; "Safety and Feasibility of Dose Escalated Pelvic Lymph Node Intensity Modulated Radiation Therapy (IMRT) with A Simultaneous Hypo-fractionated Boost to the Prostate for High Risk Adenocarcinoma of the Prostate, a Prospective Phase II Clinical Trial" 2/23/2019. IN PRESS.
55. Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline Practical Radiation Oncology. September - October 2019;9(5):322-332.
56. Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA. A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer Physics and Imaging in Radiation Oncology. October 2019;12:22-29.
57. Liang Y, Schott D, Zhang Y, Wang Z, Nasief H, Paulson E, Hall W, Knechtges P, Erickson B, Li XA. Auto-segmentation of pancreatic tumor in multi-parametric MRI using deep convolutional neural networks. Radiother Oncol. 2020 04;145:193-200.
58. Nasief H, Hall W, Zheng C, Tsai S, Wang L, Erickson B, Li XA. Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. Front Oncol. 2019;9:1464. PMCID: PMC6960122
59. Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. Front Oncol. 2020;10:500. PMCID: PMC7180175
60. Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience Clinical and Translational Radiation Oncology. July 2020;23:72-79.
61. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. HPB (Oxford). 2020 12;22(12):1745-1752.
62. Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience. Clin Transl Radiat Oncol. 2020 Jul;23:72-79. PMCID: PMC7256110
63. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy Frontiers in Oncology. 7 September 2020;10.
64. Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA. A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging–Guided Online Adaptive Radiation Therapy: A Feasibility Study Advances in Radiation Oncology. 1 November 2020;5(6):1350-1358.
65. Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR. Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage Clinical Genitourinary Cancer. 2020.
66. W.A. Hall, D. Lans, C. Arce-Lara, M.J. Kelley, R. Santana-Davila, D.M. Marcus, S. Tsai, T. Ridolfi, B.A. Erickson, E.M. Gore. Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA) International Journal of Radiation Oncology, Biology, Physics. .
67. D. Schott W.A. Hall T. Gilat Schmidt E. Dalah K. Oshima E.S. Paulson P.M. Knechtges B.A. Erickson A. Li. Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer International Journal of Radiation Oncology, Biology, Physics. ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016.
68. W.A. Hall E.S. Paulson A. Vistocky S. Tsai E.J. Koay P.M. Knechtges D. Evans K. Christians P. Ritch B. George K. Oshima A. Li B.A. Erickson. Pancreatic Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Radiomic Metrics Correlate With Pathologic Molecular Markers: An Exploratory Analysis International Journal of Radiation Oncology, Biology, Physics. POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E178-E179, OCTOBER 01, 2016.
69. S. Moningi A. Amer L.E. Colbert Y. Lee W.A. Hall B.A. Erickson G.R. Varadhachary P. Das C.M. Taniguchi J.B. Fleming M. Katz C.H. Crane E.J. Koay. A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy International Journal of Radiation Oncology, Biology, Physics. POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016.
70. D. Watkins Bruner S.L. Pugh W.R. Lee J.J. Dignam D. Low G.P. Swanson A.B. Shah D.P. D'Souza J.M. Michalski I.S. Dayes S.A. Seaward P.L. Nguyen W.A. Hall T.M. Pisansky Y. Chen H.M. Sandler B. Movsas . NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results International Journal of Radiation Oncology, Biology, Physics. ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S2-S3, OCTOBER 01, 2016.
71. L.E. Colbert K.V. Dharmarajan J. Switchenko C.M. Taniguchi W.A. Hall T.W. Gillespie D.A. Kooby J. Lipscomb J.C. Landry. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB) International Journal of Radiation Oncology, Biology, Physics. EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S195, OCTOBER 01, 2016.
72. Beinhoff P, Sabharwal L, Udhane V, Maranto C, Laviolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT. Second-generation jak2 inhibitors for advanced prostate cancer: Are we ready for clinical development? Cancers. October-2 2021;13(20).